Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05185739
Title Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) (PRIMER-1)
Acronym PRIMER-1
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Queen Elizabeth Hospital RECRUITING Birmingham United Kingdom Details
Addenbrooke's Hospital RECRUITING Cambridge United Kingdom Details
Western General Hospital NOT_YET_RECRUITING Edinburgh EH4 2XU United Kingdom Details
Beatson West of Scotland Cancer Centre NOT_YET_RECRUITING Glasgow United Kingdom Details
St James's Hospital NOT_YET_RECRUITING Leeds United Kingdom Details
Clatterbridge Cancer Centre NOT_YET_RECRUITING Liverpool United Kingdom Details
Hammersmith Hospital RECRUITING London United Kingdom Details
King's College Hospital RECRUITING London United Kingdom Details
Royal Free Hospital RECRUITING London United Kingdom Details
The Christie NHS Foundation Trust NOT_YET_RECRUITING Manchester United Kingdom Details
Freeman Hospital RECRUITING Newcastle Upon Tyne United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field